(The disease returned in seven out of the eight ... we should be moving as quickly as possible to realize that potential. Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health ...

Jarvis said there were missteps in early pandemic policy and scientific advice, as researchers struggled to learn about the disease as quickly as it spread. He worries about how the pandemic is being ...

That creates a pocket of vulnerability that can allow the disease to rip through a community ... U.S. will soon have a lot more kindling. Lisa Jarvis is a Bloomberg Opinion columnist covering ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients ...

Like most mornings throughout her life of 80 years, Annie Jarvis awakened at 5 a.m. sharp, put on a pot of strong coffee, and checked the front stoop for the ...

DOCTORS are warning parents that ‘chickenpox parties’ are never a good idea. The gatherings – which aim to expose children to the virus to ‘get it over with’ – ...

JADE JARVIS SPOKE WITH A LOCAL INFECTIOUS DISEASE SPECIALIST ABOUT STAYING HEALTHY. JADE. WELL, TIFFANY AND FELICIA, THE INFECTIOUS DISEASE SPECIALIST I SPOKE WITH, SAYS HE’S URGING PEOPLE TO ...

The parakeets commonly kept as pets could offer fresh clues about vocal learning and potential treatments for speech ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. A measles outbreak ...

Lisa Jarvis is a Bloomberg Opinion columnist covering ... for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients, but it ...

(The disease returned in seven out of the eight people whose immune ... we should be moving as quickly as possible to realize ...

A study published last month in Nature highlighted the potential for a new personalized pancreatic cancer vaccine. The trial was tiny, just 16 patients, but it’s ...